Tradestie Institutional Equity Comparison Engine
AFJK vs EVAC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EVAC Overall Edge
EVAC Captures Institutional Edge (2โ0 Pillars ยท 5โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to EQV Ventures Acquisition Corp. II (EVAC) driven by superior Valuation, Momentum & Technical. Fundamentally, AFJK trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus EVAC at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, AFJK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against EVAC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
EVAC
AFJK N/M vs EVAC N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
EVAC
1Y +3.3% vs +4.0% ยท 52W Pos 4% vs 100%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
AFJK
US Equity
Aimei Health Technology Co., Ltd
Blank Checks
$11.78
-1.01% 1D
Market Cap
$37.7M
1M Return
-4.0%
1Y Return
+3.33%
Forward P/E
N/M
Unified AI Score
48.1 / 100
HOLD
Tech 62.0
Fund 46.0
Flow 50.0
Mom 35.0
EVAC
NYSE
EQV Ventures Acquisition Corp. II
Blank Checks
$10.43
+0.48% 1D
Market Cap
$606.7M
1M Return
+0.97%
1Y Return
+3.99%
Forward P/E
N/M
Unified AI Score
54.7 / 100
HOLD
Tech 35.0
Fund 52.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
AFJK +3.33%
EVAC +3.99%
Spread: +3.31 pp (EVAC Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
AFJK TTM Op. Margin: 0.0%
EVAC TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AFJK vs EVAC. Trailing 12-month operating profitability (AFJK 0.0% vs EVAC 0.0%) and valuation multiples (AFJK N/M vs EVAC N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AFJK | EVAC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $37.7M | $606.7M | Larger Scale | EVAC |
| Trailing P/E Ratio Valuation | N/M | 35.8x | Lower Multiple | EVAC |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | 0.0% | 0.0% | Higher ROE | Tie |
| 52-Week Range Position Momentum | 4% ($7โ$130) | 100% ($10โ$10) | Stronger Trend | EVAC |
| Beta / 30D Volatility Risk Regime | 0.96ฮฒ ยท 28% Vol | 0.02ฮฒ ยท 1% Vol | Lower Realized Risk | EVAC |
| Unified Institutional Score Composite Signal | 48.1 / 100 (HOLD) | 54.7 / 100 (HOLD) | Higher Composite | EVAC |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full AFJK vs EVAC Buy Guide
AFJK
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
EVAC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither AFJK nor EVAC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.